celiprolol has been researched along with Cardiovascular Diseases in 3 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study compares the antihypertensive and lipid modifying effects of treatment of mild to moderate hypertension with celiprolol or atenolol." | 3.69 | A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients. ( Jackson, RT; Milne, RJ; Vander Hoorn, S, 1997) |
| "Celiprolol is a third-generation beta-adrenoceptor blocker with selective beta 1-antagonist, partial beta 2-agonist and mild alpha 2-antagonist actions." | 2.39 | A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease. ( Kendall, MJ; Rajman, I, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, KY | 1 |
| Tseng, PT | 1 |
| Wu, YC | 1 |
| Tu, YK | 1 |
| Stubbs, B | 1 |
| Su, KP | 1 |
| Matsuoka, YJ | 1 |
| Hsu, CW | 1 |
| Lin, CH | 1 |
| Chen, YW | 1 |
| Lin, PY | 1 |
| Kendall, MJ | 1 |
| Rajman, I | 1 |
| Milne, RJ | 1 |
| Vander Hoorn, S | 1 |
| Jackson, RT | 1 |
2 reviews available for celiprolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Ce | 2021 |
A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Carbohydrate Metabolism; Cardiovascular Diseases; Celiprolol; Drug Tole | 1994 |
1 other study available for celiprolol and Cardiovascular Diseases
| Article | Year |
|---|---|
A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Cardiovascular Diseases; Celiprolol; Female; Hum | 1997 |